Risk & Disruption
High ImpactNov 9, 2026U.S. Government Assesses Drug Supply Chain Vulnerabilities
The U.S. government has initiated an assessment of vulnerabilities within the pharmaceutical supply chain. This proactive review aims to identify critical weaknesses in drug manufacturing, distributio
BenefitsPRO#drug-supply-chain#pharma-vulnerabilities#supply-chain-risk